Skip to main navigation Skip to search Skip to main content

Availability of resources to apply the 2024 McDonald criteria: A global perspective

  • Natalia Gómez-Salazar
  • , Paola A. Ortíz-Salas
  • , Rebecca Wicklein
  • , Charmaine Yam
  • , Mateo Avilés-Gómez
  • , Magdalena Casas
  • , Marija Cauchi
  • , Sofía D’Alessandro
  • , Michela Galimberti
  • , Panagiotis Gklinos
  • , Fernando Maldonado-Higuera
  • , Suhamny Navas-Peñaranda
  • , Tatchaporn Ongphichetmetha
  • , Alejandro A. Pelaez-Suarez
  • , Wilson A. Polo-Orcasitas
  • , André L.Guimarães de Queiroz
  • , Audrey Reynolds
  • , Neda Sattarnezhad
  • , Raquel Tena-Cucala
  • , Oana Vladacenco
  • Mario M. Barbosa-Rengifo, Wallace Brownlee, Mar Tintoré
  • Universidad del Rosario
  • Fundación Cardioinfantil-Instituto de Cardiología. Bogotá
  • Technical University of Munich
  • Brighton and Sussex University Hospitals NHS Trust
  • University College London
  • Ramos Mejia Hospital
  • Mater Dei Hospital
  • Hospital San Martín de La Plata
  • Accord /UP
  • San Gerardo Hospital
  • University of Milano-Bicocca
  • Eginition Hospital
  • Universidad San Sebastián
  • Hospital Dr. Eduardo Schutz Schroeder
  • Instituto Nacional de Neurología y Neurocirugía
  • Hospital Israelita Albert Einstein
  • University College Dublin
  • Tallaght University Hospital
  • Stanford University
  • Veterans Affairs Palo Alto Healthcare System
  • Hospital Verge de la Cinta
  • Carol Davila University of Medicine and Pharmacy
  • Universidad Icesi
  • Fundación Valle del Lili
  • University Hospital Vall d'Hebron

Research output: Contribution to journal › Article › peer-review

Abstract

Background: The 3rd ECTRIMS Winter School highlighted regional and global disparities in resources needed to implement the 2024 McDonald diagnostic criteria for multiple sclerosis. Objectives: To assess the availability of paraclinical tools and regional differences in access reported by neurologists in an online survey. Results: The survey was completed by 328 neurologists from 44 countries. Core diagnostic tools, including magnetic resonance imaging and oligoclonal band testing, were widely available. Access to advanced imaging, optic nerve assessment, and laboratory biomarkers varied across regions. Conclusions: Variability in access to key paraclinical tests may impact on the implementation of the 2024 McDonald criteria globally.

Original languageEnglish
JournalMultiple Sclerosis Journal
DOIs
Publication statusAccepted/In press - 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • diagnostic techniques
  • epidemiology
  • health services accessibility
  • multiple sclerosis
  • neurological

Cite this